Michael D Scholle

age ~50

from Downers Grove, IL

Get Report

Also known as:

Nichael D Scholle

Phone and address:: 412 Franklin St, Downers Grove, IL 60515
847 697-7120

Connected to:

Michael Scholle Phones & Addresses

412 Franklin St, Downers Grove, IL 60515 • 847 697-7120
Bolingbrook, IL
100 Whisman Rd, Mountain View, CA 94043
Cape Coral, FL
1658 College Green Dr, Elgin, IL 60123 • 847 697-7120
39W195 Chisholm Trl, Elgin, IL 60123 • 847 429-1172
Willeys, IL
Kane, IL

Name / Title

Company / Classification

Phones & Addresses

Michael D. Scholle
Director

Samdi Tech, Inc
Research and Development

552 N Vine St, Oak Brook, IL 60521

Resumes

Michael Scholle

view source

Director At Samdi Tech Inc

view source

Position:

Director of Technology and Operations at SAMDI Tech Inc.

Location:

Greater Chicago Area

Industry:

Biotechnology

Work:

SAMDI Tech Inc. - Chicago, IL since Jan 2011
Director of Technology and Operations
University of Chicago - Chicago, IL Jul 2009 - Aug 2011
Research Professional
Amunix Inc - Mountain View, CA Jan 2006 - Jul 2009
Scientist and Operations Manager
Argonne National Laboratory - Chicago, IL Apr 2002 - Jan 2006
Senior Research Associate / Lab Manager
Integrated Genomics - Chicago, IL Jan 2001 - Apr 2002
Advanced Research Assistant

Education:

Roosevelt University 2003 - 2005
M.B.A., Marketing Northern Illinois University 1998 - 2000
M.S., Molecular Microbiology Northern Illinois University 1994 - 1998
B.S., Biology

Skills:

Surface Chemistry
Automation
Enzyme Assays
Enzyme Kinetics
Technology Development
Molecular Biology
Protein Expression
Protein Purification
ELISA
Western Blotting
Phage Display
Grant Writing
Biochemistry
High Throughput Screening
Drug Discovery
Mass Spectrometry
Antibodies
Biotechnology
Assay Development

Interests:

Epigenetics, high-throughput drug discovery, surface chemistry, label-free biochemical assay development and substrate profiling, phage display

Honor & Awards:

NSF SBIR Phase I and Phase IB grant awardee

Us Patents

Unstructured Recombinant Polymers And Uses Thereof
view source
US Patent:

7855279, Dec 21, 2010
Filed:

Mar 6, 2007
Appl. No.:

11/715276
Inventors:

Volker Schellenberger - Palo Alto CA, US
Willem P. Stemmer - Los Gatos CA, US
Chia-wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
Assignee:

Amunix Operating, Inc. - Mountain View CA
International Classification:

A61K 38/24
C40B 50/18
US Classification:

530399, 530324, 530350, 530300
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.

Unstructured Recombinant Polymers And Compositions Comprising Same
view source
US Patent:

8492530, Jul 23, 2013
Filed:

Nov 3, 2010
Appl. No.:

12/939120
Inventors:

Volker Schellenberger - Palo Alto CA, US
Willem P. Stemmer - Los Gatos CA, US
Chia-Wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
Assignee:

Amunix Operating Inc. - Mountain View CA
International Classification:

A61K 38/24
A23J 1/00
C40B 50/18
US Classification:

530399, 530350, 530324, 530417, 435 4
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.

Proteinaceous Pharmaceuticals And Uses Thereof
view source
US Patent:

20070191272, Aug 16, 2007
Filed:

Sep 27, 2006
Appl. No.:

11/528927
Inventors:

Willem Stemmer - Los Gatos CA, US
Volker Schellenberger - Palo Alto CA, US
Martin Bader - Mountain View CA, US
Michael Scholle - Mountain View CA, US
International Classification:

A61K 38/16
C40B 40/08
C40B 40/10
C07K 14/47
US Classification:

514012000, 435007100, 435006000, 530324000
Abstract:

The present invention provides cysteine-containing scaffolds and/or proteins, expression vectors, host cell and display systems harboring and/or expressing such cysteine-containing products. The present invention also provides methods of designing libraries of such products, methods of screening such libraries to yield entities exhibiting binding specificities towards a target molecule. Further provided by the invention are pharmaceutical compositions comprising the cysteine-containing products of the present invention.

Proteinaceous Pharmaceuticals And Uses Thereof
view source
US Patent:

20070212703, Sep 13, 2007
Filed:

Sep 27, 2006
Appl. No.:

11/528950
Inventors:

Willem Stemmer - Los Gatos CA, US
Volker Schellenberger - Palo Alto CA, US
Martin Bader - Mountain View CA, US
Michael Scholle - Mountain View CA, US
International Classification:

C40B 40/02
C40B 40/08
C40B 40/10
US Classification:

435006000, 435472000, 435252300, 530350000, 530388100
Abstract:

The present invention provides cysteine-containing scaffolds and/or proteins, expression vectors, host cell and display systems harboring and/or expressing such cysteine-containing products. The present invention also provides methods of designing libraries of such products, methods of screening such libraries to yield entities exhibiting binding specificities towards a taraget molecule. Further provided by the invention are pharmaceutical compositions comprising the cysteine-containing products of the present invention.

Methods For Production Of Unstructured Recombinant Polymers And Uses Thereof
view source
US Patent:

20080286808, Nov 20, 2008
Filed:

Mar 6, 2007
Appl. No.:

11/715296
Inventors:

Volker Schellenberger - Palo Alto CA, US
Willem P. Stemmer - Los Gatos CA, US
Chia-wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
International Classification:

G01N 33/53
C12P 21/02
C07K 19/00
C07K 1/107
G01N 33/566
US Classification:

435 78, 435 691, 530324, 530409
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.

Genetic Package And Uses Thereof
view source
US Patent:

20090099031, Apr 16, 2009
Filed:

Mar 6, 2007
Appl. No.:

11/715300
Inventors:

Willem P. Stemmer - Los Gatos CA, US
Volker Schellenberger - Palo Alto CA, US
Chia-wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
International Classification:

C40B 30/04
C40B 40/10
C07K 2/00
C12N 5/06
C12N 15/00
C12N 15/11
C40B 30/00
US Classification:

506 9, 506 18, 530300, 506 7, 536 231, 435325, 4353201
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.

Biologically Active Proteins Having Increased In Vivo And/Or In Vitro Stability
view source
US Patent:

20100189682, Jul 29, 2010
Filed:

Dec 9, 2009
Appl. No.:

12/634556
Inventors:

Volker Schellenberger - Palo Alto CA, US
Willem P. Stemmer - Los Gatos CA, US
Chia-wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
International Classification:

A61K 38/20
C07K 14/00
A61K 38/16
C07K 16/00
A61K 39/395
C07K 14/52
C07K 14/475
C07H 21/04
A61P 37/00
A61P 35/00
A61P 3/10
A61P 9/10
A61P 13/12
A61P 7/02
A61P 29/00
A61K 38/21
C12N 9/00
C12N 15/63
C12N 5/10
C12P 21/02
US Classification:

424 852, 530350, 514 12, 5303871, 4241301, 530399, 536 231, 536 2351, 536 235, 536 2353, 536 232, 424 857, 424 856, 424 855, 536 2352, 530351, 435183, 4353201, 435325, 435 691
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.

Methods For Production Of Unstructured Recombinant Polymers And Uses Thereof
view source
US Patent:

20110151433, Jun 23, 2011
Filed:

Nov 3, 2010
Appl. No.:

12/939129
Inventors:

Volker Schellenberger - Palo Alto CA, US
Willem P. Stemmer - Los Gatos CA, US
Chia-Wei Wang - Santa Clara CA, US
Michael D. Scholle - Mountain View CA, US
Mikhail Popkov - San Diego CA, US
Nathaniel C. Gordon - Campbell CA, US
Andreas Crameri - Los Altos Hills CA, US
Assignee:

Amunix Operating, Inc. - Mountain View CA
International Classification:

C12Q 1/68
C12P 21/00
C07K 1/00
G01N 33/53
C12Q 1/70
US Classification:

435 5, 435 691, 530409, 436501, 435 61
Abstract:

The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.